T1 and T2 mapping for early diagnosis of dilated non-ischaemic cardiomyopathy in middle-aged patients and differentiation from normal physiological adaptation

European Heart Journal Cardiovascular Imaging

Volumn 17, Issue 7, 2016, Pages 797-803

  Mordi, Ify ^a   Carrick, David ^a   Bezerra, Hiram ^b   Tzemos, Nikolaos ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Athletes; Cardiovascular magnetic resonance; Dilated cardiomyopathy; T1 mapping; T2 mapping

Indexed keywords

ADAPTATION; ADULT; AEROBIC EXERCISE; AREA UNDER THE CURVE; ARTICLE; ATHLETE; CARDIAC MAPPING SYSTEM; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DILATATION; EARLY DIAGNOSIS; EXTRACELLULAR SPACE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MALE; MIDDLE AGED; NONISCHEMIC CARDIOMYOPATHY; PRIORITY JOURNAL; SITTING; TISSUE CHARACTERIZATION; ANALYSIS OF VARIANCE; CASE CONTROL STUDY; CINE MAGNETIC RESONANCE IMAGING; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; EXERCISE TOLERANCE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART STROKE VOLUME; IMAGE PROCESSING; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; REFERENCE VALUE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

ADAPTATION, PHYSIOLOGICAL; ANALYSIS OF VARIANCE; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; EARLY DIAGNOSIS; EXERCISE TOLERANCE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 84988908259     PISSN: 20472404     EISSN: 20472412     Source Type: Journal    
DOI: 10.1093/ehjci/jev216     Document Type: Article

References (36)

1. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012;33: 1787-1847.
2. Rapezzi C, Arbustini E, Caforio AL, Charron P, Gimeno-Blanes J, Helio T et al. Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESCWorking Group on Myocardial and Pericardial Diseases. Eur Heart J 2013;34:1448-58.
3. Lakdawala NK, Winterfield JR, Funke BH. Dilated cardiomyopathy. Circ Arrhythm Electrophysiol 2013;6:228-37.
4. Jefferies JL, Towbin JA. Dilated cardiomyopathy. Lancet 2010;375:752-62.
5. La Gerche A, Taylor AJ, Prior DL. Athlete's heart: the potential for multimodality imaging to address the critical remaining questions. JACC Cardiovasc Imaging 2009;2: 350-63.
6. Abergel E, Chatellier G, Hagege AA, Oblak A, Linhart A, Ducardonnet A et al. Serial left ventricular adaptations in world-class professional cyclists: implications for disease screening and follow-up. J Am Coll Cardiol 2004;44:144-9.
7. Utomi V, Oxborough D, Ashley E, Lord R, Fletcher S, Stembridge M et al. Predominance of normal left ventricular geometry in the male 'athlete's heart'. Heart 2014; 100:1264-71.
8. Zilinski JL, Contursi ME, Isaacs SK, Deluca JR, Lewis GD,Weiner RB et al. Myocardial adaptations to recreational marathon training among middle-aged men. Circ Cardiovasc Imaging 2015;8:e002487.
9. Mohlenkamp S, Lehmann N, Breuckmann F, Brocker-Preuss M, Nassenstein K, Halle M et al. Running: the risk of coronary events: prevalence and prognostic relevance of coronary atherosclerosis in marathon runners. Eur Heart J 2008;29: 1903-10.
10. Mahrholdt H,Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 2005;26:1461-74.
11. McCrohon JA, Moon JC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJ et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003;108:54-9.
12. Assomull RG, Prasad SK, Lyne J, Smith G, Burman ED, Khan M et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006;48:1977-85.
13. Gulati A, Jabbour A, Ismail TF, Guha K, Khwaja J, Raza S et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA 2013;309:896-908.
14. Galderisi M, Cardim N, D'Andrea A, Bruder O, Cosyns B, Davin L et al. The multimodality cardiac imaging approach to the Athlete's heart: an expert consensus of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2015;16:353.
15. Puntmann VO, Voigt T, Chen Z, Mayr M, Karim R, Rhode K et al. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC Cardiovasc Imaging 2013;6:475-84.
16. Dass S, Suttie JJ, Piechnik SK, Ferreira VM, Holloway CJ, Banerjee R et al. Myocardial tissue characterization using magnetic resonance noncontrast T1 mapping in hypertrophic and dilated cardiomyopathy. Circ Cardiovasc Imaging 2012;5:726-33.
17. Nishii T, Kono AK, Shigeru M, Takamine S, Fujiwara S, Kyotani K et al. Cardiovascular magnetic resonance T2 mapping can detect myocardial edema in idiopathic dilated cardiomyopathy. Int J Cardiovasc Imaging 2014;30(Suppl 1):65-72.
18. Mordi I, Jhund PS, Gardner RS, Payne J, Carrick D, Berry C et al. LGE and NT-proBNP identify low risk of death or arrhythmic events in patients with primary prevention ICDs. JACC Cardiovasc Imaging 2014;7:561-9.
19. Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP. Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med 2004;52:141-6.
20. Giri S, Chung YC, Merchant A, Mihai G, Rajagopalan S, Raman SV et al. T2 quantification for improved detection of myocardial edema. J Cardiovasc Magn Reson 2009; 11:56.
21. Arheden H, Saeed M, Higgins CB, Gao DW, Bremerich J, Wyttenbach R et al. Measurement of the distribution volume of gadopentetate dimeglumine at echoplanar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. Radiology 1999;211:698-708.
22. Kramer CM, Chandrashekhar Y, Narula J. T1 mapping by CMR in cardiomyopathy: a noninvasive myocardial biopsy? JACC Cardiovasc Imaging 2013;6:532-4.
23. Parsai C, O'Hanlon R, Prasad SK, Mohiaddin RH. Diagnostic and prognostic value of cardiovascular magnetic resonance in non-ischaemic cardiomyopathies. J Cardiovasc Magn Reson 2012;14:54.
24. Antony R, Daghem M, McCann GP, Daghem S, Moon J, Pennell DJ et al. Cardiovascular magnetic resonance activity in the United Kingdom: a survey on behalf of the British Society of Cardiovascular Magnetic Resonance. J Cardiovasc Magn Reson 2011;13:57.
25. aus dem Siepen F, Buss SJ, Messroghli D, Andre F, Lossnitzer D, Seitz S et al. T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy. Eur Heart J Cardiovasc Imaging 2015;16:210-6.
26. Pluim BM, Zwinderman AH, van der Laarse A, van derWall EE. The athlete's heart. A meta-analysis of cardiac structure and function. Circulation 2000;101:336-44.
27. Maron BJ, Pelliccia A. The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death. Circulation 2006;114:1633-44.
28. Whyte GP, Sheppard M, George KP, Shave RE, Wilson M, Stephens N et al. Arrhythmias and the athlete: mechanisms and clinical significance. Eur Heart J 2007; 28:1399-401
29. Waterhouse DF, Ismail TF, Prasad SK, Wilson MG, O'Hanlon R. Imaging focal and interstitial fibrosis with cardiovascular magnetic resonance in athletes with left ventricular hypertrophy: implications for sporting participation. Br J Sports Med 2012; 46(Suppl 1):i69-77.
30. Ugander M, Bagi PS, Oki AJ, Chen B, Hsu LY, Aletras AH et al. Myocardial edema as detected by pre-contrast T1 and T2 CMR delineates area at risk associated with acute myocardial infarction. JACC Cardiovasc Imaging 2012;5:596-603.
31. Kono AK, Croisille P, Nishii T, Nishiyama K, Kyotani K, Shigeru M et al. Cardiovascular magnetic resonance tagging imaging correlates with myocardial dysfunction and T2 mapping in idiopathic dilated cardiomyopathy. Int J Cardiovasc Imaging 2014;30(Suppl 2):145-52.
32. Jeserich M, Foll D, Olschewski M, Kimmel S, Friedrich MG, Bode C et al. Evidence of myocardial edema in patients with nonischemic dilated cardiomyopathy. Clin Cardiol 2012;35:371-6.
33. Liu CY, Liu YC, Wu C, Armstrong A, Volpe GJ, van der Geest RJ et al. Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2013;62:1280-7.
34. Breuckmann F, Mohlenkamp S, Nassenstein K, Lehmann N, Ladd S, Schmermund A et al. Myocardial late gadolinium enhancement: prevalence, pattern, and prognostic relevance in Marathon runners. Radiology 2009;251:50-7.
35. Piechnik SK, Ferreira VM, Lewandowski AJ, Ntusi NA, Banerjee R, Holloway C et al. Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI. J Cardiovasc Magn Reson 2013;15:13.
36. Moon JC, Messroghli DR, Kellman P, Piechnik SK, Robson MD, Ugander M et al. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson 2013;15:92.